Free Webinar Invitation: A Critical Review of the Recent FDA Approved Anti-Amyloid Drugs for Alzheimer's Disease


The Alzheimer International Society is hosting a webinar during the CTAD 2023 Conference in Boston, USA:

Topic: A Critical Review of the Recent FDA Approved Anti-Amyloid Drugs for Alzheimer's Disease

Date: Thursday, October 26, 2023, at 10:00 AM EST

Location: Zoom webinar

During the webinar, our panelists will:

  1. Take a close look at the clinical data inconsistencies and perceived shortcomings regarding the FDA approvals of Aducanumab and Lecanumab.
  2. Discuss the stance of the Centers for Medicare & Medicaid Services (CMS) on anti-amyloid drugs and their recent decision concerning Lecanemab's federal registry system.
  3. Offer insights into the FDA's decision and its implications for patients, healthcare professionals, insurers, and other stakeholders.

Our panel of distinguished Alzheimer’s researchers and key opinion leaders includes:

  • Alberto J. Espay, MD, MSc, FAAN - Professor of Neurology and Director, University of Cincinnati Academic Health Center
  • Bryce Vissel, Ph.D. - Head of the Centre for Neuroscience and Regenerative Medicine
  • Zung Vu Tran, Ph.D. - Retired Research Professor, Department of Biostatistics & Informatics, Colorado School of Public Health, University of Colorado
  • Karl Herrup, Ph.D. - Professor of Neurology and Investigator, Alzheimer’s Disease Research Center, University of Pittsburgh
  • Rudolph Castellani, M.D. - Director of the Neuropathology Core, Northwestern University Feinberg School of Medicine
  • Nikos Robakis, Ph.D. - A.P. Slaner Professor, Alzheimer’s Disease Research Center, Icahn School of Medicine at Mount Sinai

Your active participation will be welcome during the interactive Q&A after the main discussion.

To attend please complete the registration form (free):


Alzheimer International Society